The DOI matches its Crossref record.
Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release
Abstract
Macroporous chitosan scaffolds reinforced by β‐tricalcium phosphate (β‐TCP) and calcium phosphate invert glasses were fabricated using a thermally induced phase separation technique. These porous composite materials were specially designed as both a drug carrier for controlled drug release and a scaffold for bone regeneration. The controlled drug release of antibiotic gentamicin‐sulfate (GS) loaded scaffolds and morphology of osteosarcoma MG63 cells cultured on the scaffolds were studied. In comparison with the GS loaded pure chitosan scaffolds, the initial burst release of GS was decreased through incorporating calcium phosphate crystals and glasses into the scaffolds, and the sustained release for more than 3 weeks was achieved. The possible mechanisms for the controlled drug release were investigated by SEM, FTIR, and measurements of the pH values of the PBS solution during the drug release test. SEM micrographs showed no apparent morphological differences for osteoblastic cells grown on the pure chitosan scaffolds and those grown on composite scaffolds. The cells were attached and migrated on these scaffolds, and exhibited a biological appearance, suggesting a good cellular compatibility. © 2002 Wiley Periodicals, Inc. J Biomed Mater Res 62: 378–386, 2002
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Chitosan—A versatile semi-synthetic polymer in biomedical applications
Dash, M., Chiellini, F., Ottenbrite, R. M., & Chiellini, E. (2011) · Progress in Polymer Science · doi:10.1016/j.progpolymsci.2011.02.001 · Cited by 2,903
Implantable applications of chitin and chitosan
Khor, E., & Lim, L. Y. (2003) · Biomaterials · doi:10.1016/s0142-9612(03)00026-7 · Cited by 1,672
Chitosan: A versatile biopolymer for orthopaedic tissue-engineering
Di Martino, A., Sittinger, M., & Risbud, M. V. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.016 · Cited by 1,634
Chitosan and its derivatives for tissue engineering applications
Kim, I.-Y., Seo, S.-J., Moon, H.-S., Yoo, M.-K., Park, I.-Y., Kim, B.-C., & Cho, C.-S. (2008) · Biotechnology Advances · doi:10.1016/j.biotechadv.2007.07.009 · Cited by 1,433
Chitins and chitosans for the repair of wounded skin, nerve, cartilage and bone
Muzzarelli, R. A. A. (2009) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2008.11.002 · Cited by 1,103
Eliaz, N., & Metoki, N. (2017) · Materials · doi:10.3390/ma10040334 · Cited by 1,088
Chitosan–alginate hybrid scaffolds for bone tissue engineering
Li, Z., Ramay, H. R., Hauch, K. D., Xiao, D., & Zhang, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.09.062 · Cited by 1,044
Self-citationBose, S., & Tarafder, S. (2012) · Acta Biomaterialia · doi:10.1016/j.actbio.2011.11.017 · Cited by 958
Electrospun chitosan-based nanofibers and their cellular compatibility
Bhattarai, N., Edmondson, D., Veiseh, O., Matsen, F. A., & Zhang, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2005.03.027 · Cited by 898
Self-citationChitin and Chitosan: Structure, Properties and Applications in Biomedical Engineering
Islam, S., Bhuiyan, M. A. R., & Islam, M. N. (2017) · Journal of Polymers and the Environment · doi:10.1007/s10924-016-0865-5 · Cited by 738
Ceramic composites as matrices and scaffolds for drug delivery in tissue engineering
Habraken, W. J. E. M., Wolke, J. G. C., & Jansen, J. A. (2007) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2007.03.011 · Cited by 566
Scaffold: A Novel Carrier for Cell and Drug Delivery
Garg, T., Singh, O., Arora, S., & Murthy, R. S. R. (2012) · Critical Reviews in Therapeutic Drug Carrier Systems · doi:10.1615/critrevtherdrugcarriersyst.v29.i1.10 · Cited by 549
Staphylococcal Osteomyelitis: Disease Progression, Treatment Challenges, and Future Directions
Kavanagh, N., Ryan, E. J., Widaa, A., Sexton, G., Fennell, J., O'Rourke, S., Cahill, K. C., Kearney, C. J., O'Brien, F. J., & Kerrigan, S. W. (2018) · Clinical Microbiology Reviews · doi:10.1128/cmr.00084-17 · Cited by 547
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds
Mouriño, V., & Boccaccini, A. R. (2010) · Journal of The Royal Society Interface · doi:10.1098/rsif.2009.0379 · Cited by 527
Hu, Q., Li, B., Wang, M., & Shen, J. (2004) · Biomaterials · doi:10.1016/s0142-9612(03)00582-9 · Cited by 466
Mouriño, V., Cattalini, J. P., & Boccaccini, A. R. (2012) · Journal of The Royal Society Interface · doi:10.1098/rsif.2011.0611 · Cited by 441
New Generation of Multifunctional Nanoparticles for Cancer Imaging and Therapy
Park, K., Lee, S., Kang, E., Kim, K., Choi, K., & Kwon, I. C. (2009) · Advanced Functional Materials · doi:10.1002/adfm.200801655 · Cited by 432
Review: Development of clinically relevant scaffolds for vascularised bone tissue engineering
Liu, Y., Lim, J., & Teoh, S.-H. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2012.10.003 · Cited by 427
Alizadeh-Osgouei, M., Li, Y., & Wen, C. (2019) · Bioactive Materials · doi:10.1016/j.bioactmat.2018.11.003 · Cited by 356
Calcium phosphate nanoparticles in biomineralization and biomaterials
Cai, Y., & Tang, R. (2008) · Journal of Materials Chemistry · doi:10.1039/b805407j · Cited by 300
Calcium orthophosphate-based biocomposites and hybrid biomaterials
Dorozhkin, S. V. (2009) · Journal of Materials Science · doi:10.1007/s10853-008-3124-x · Cited by 300
Kwon, S., Park, J. H., Chung, H., Kwon, I. C., Jeong, S. Y., & Kim, I.-S. (2003) · Langmuir · doi:10.1021/la0350608 · Cited by 269
Recent advances in theranostic polymeric nanoparticles for cancer treatment: A review
Indoria, S., Singh, V., & Hsieh, M.-F. (2020) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2020.119314 · Cited by 168
Metadata
- Authors
- Zhang, Y., & Zhang, M.
- Venue
- Journal of Biomedical Materials Research
- Publisher
- Wiley
- Published
- 2002-08-06
- Volume
- 62
- Issue
- 3
- Pages
- 378-386
- ISSN
- 0021-9304 (ISSN-L)
- 1097-4636
- OpenAlex
- W1966329484
- Cited by
- 233
- References
- 0
- FWCI
- 6.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.